Your browser doesn't support javascript.
loading
Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review.
Guan, Huifang; Tian, Jiaxing; Wang, Ying; Niu, Ping; Zhang, Yuxin; Zhang, Yanjiao; Fang, Xinyi; Miao, Runyu; Yin, Ruiyang; Tong, Xiaolin.
Affiliation
  • Guan H; College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • Tian J; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. tina_yai@126.com.
  • Wang Y; College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • Niu P; Rehabilitation Department, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130021, China.
  • Zhang Y; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
  • Zhang Y; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
  • Fang X; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
  • Miao R; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Yin R; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
  • Tong X; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
Eur J Med Res ; 29(1): 152, 2024 Mar 04.
Article in En | MEDLINE | ID: mdl-38438934
ABSTRACT
Type 2 diabetes mellitus (T2DM) poses a significant global health burden. This is particularly due to its macrovascular complications, such as coronary artery disease, peripheral vascular disease, and cerebrovascular disease, which have emerged as leading contributors to morbidity and mortality. This review comprehensively explores the pathophysiological mechanisms underlying these complications, protective strategies, and both existing and emerging secondary preventive measures. Furthermore, we delve into the applications of experimental models and methodologies in foundational research while also highlighting current research limitations and future directions. Specifically, we focus on the literature published post-2020 concerning the secondary prevention of macrovascular complications in patients with T2DM by conducting a targeted review of studies supported by robust evidence to offer a holistic perspective.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Diabetes Mellitus, Type 2 Language: En Journal: Eur J Med Res Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Diabetes Mellitus, Type 2 Language: En Journal: Eur J Med Res Year: 2024 Type: Article Affiliation country: China